These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2361666)

  • 1. Lysozyme and secretory component in endocervical and endometrial adenocarcinoma.
    Patterson A; Wilson B; Cooper P; Arends JW
    Histopathology; 1990 May; 16(5):515-6. PubMed ID: 2361666
    [No Abstract]   [Full Text] [Related]  

  • 2. Tissue CEA test in endocervical and endometrial adenocarcinoma.
    Dufour DR; Stock RJ
    Lancet; 1980 Mar; 1(8168 Pt 1):596-7. PubMed ID: 6102315
    [No Abstract]   [Full Text] [Related]  

  • 3. Endocervical and endometrial adenocarcinoma: an immunoperoxidase and histochemical study.
    Cohen C; Shulman G; Budgeon LR
    Am J Surg Pathol; 1982 Mar; 6(2):151-7. PubMed ID: 7048944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue CEA test in endocervical and endometrial adenocarcinoma.
    Wahlström T; Seppälä M
    Lancet; 1980 Mar; 1(8168 Pt 1):597. PubMed ID: 6102317
    [No Abstract]   [Full Text] [Related]  

  • 5. Distinction between endocervical and endometrial adenocarcinoma with immunoperoxidase staining of carcinoembryonic antigen in routine histological tissue specimens.
    Wahlström T; Lindgren J; Korhonen M; Seppälä M
    Lancet; 1979 Dec; 2(8153):1159-60. PubMed ID: 91890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AgNOR counts in endometrial and endocervical carcinomas.
    Mauri FA; Muscarà M; Ferrero S; Barbareschi M; Scampini S; Perrone G
    Pathologica; 1990; 82(1080):399-403. PubMed ID: 1704497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum CA 125 and TPA determination in malignant neoplasms of the uterus].
    Gadducci A; Facchini V; Bartolini T; Fioretti P
    Ann Ostet Ginecol Med Perinat; 1988; 109(3):151-5. PubMed ID: 3207319
    [No Abstract]   [Full Text] [Related]  

  • 8. Intermediate filaments in endometrial and endocervical carcinomas. The diagnostic utility of vimentin patterns.
    Dabbs DJ; Geisinger KR; Norris HT
    Am J Surg Pathol; 1986 Aug; 10(8):568-76. PubMed ID: 2426982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical localization of carcinoembryonic antigen in adenocarcinoma of the endocervix and the endometrium.
    Toki T; Oikawa N; Tase T; Wada Y; Yajima A; Suzuki M
    Tohoku J Exp Med; 1985 May; 146(1):27-32. PubMed ID: 3895576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunohistochemical investigation of vimentin of uterine endometrial and endocervical adenocarcinoma].
    Ohwada M; Suzuki M; Tamada T
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Sep; 42(9):1237-43. PubMed ID: 2212824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation and staging of endometrial and endocervical adenocarcinoma by contact hysteroscopy.
    Baggish MS
    Gynecol Oncol; 1980 Apr; 9(2):182-92. PubMed ID: 7372191
    [No Abstract]   [Full Text] [Related]  

  • 13. The expression and localization of amylase in normal and malignant glands of the endometrium and endocervix.
    Lee YS; Raju GC
    J Pathol; 1988 Jul; 155(3):201-5. PubMed ID: 2457671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differential diagnosis of adenocarcinoma of the uterus and cervix using CEA immunohistochemical staining].
    Wahlström T; Lindgren J; Korhonen M; Seppälä M
    Duodecim; 1980; 96(11):804-7. PubMed ID: 7011782
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diagnosis of endometrial adenocarcinoma].
    Macchioni B
    Minerva Ginecol; 1976 Apr; 28(4):280-2. PubMed ID: 995316
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunohistochemical properties of the endometrial and cervical adenocarcinoma.
    Sugimori H; Ookuma Y; Iwasaka T
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Dec; 38(12):2287-8. PubMed ID: 2433372
    [No Abstract]   [Full Text] [Related]  

  • 17. Accuracy of three sampling technics for the diagnosis of endometrial cancer and hyperplasias.
    Bibbo M; Kluskens L; Azizi F; Bartels PH; Wied GL; Yamauchi K; Herbst AL
    J Reprod Med; 1982 Oct; 27(10):622-6. PubMed ID: 7175831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fruits of our labors: distinguishing endometrial from endocervical adenocarcinoma.
    Zaino RJ
    Int J Gynecol Pathol; 2002 Jan; 21(1):1-3. PubMed ID: 11781515
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic colposcopy in adenocarcinoma of the uterine cervix.
    Ueki M; Maeda T; Sano T; Sugimoto O
    Asia Oceania J Obstet Gynaecol; 1985 Mar; 11(1):113-20. PubMed ID: 4015515
    [No Abstract]   [Full Text] [Related]  

  • 20. Carcinoembryonic antigen staining of endometrial and endocervical carcinomas.
    van Nagell JR; Goldenberg JR
    Lancet; 1980 Jan; 1(8161):213. PubMed ID: 6153442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.